The Effect of GLP-1 Agonist Treatment On Subclinical Atherosclerosis
The Effect of GLP-1 Agonist Treatment On Subclinical Atherosclerosis
Abstract
The coexistence of diabetes mellitus (DM) and obesity is known to increase cardiovascular risks.
Description
Keywords
Internal Medicine, Agonist, Subclinical Infection, Medicine, Cardiology
Fields of Science
Citation
WoS Q
Scopus Q
Source
Volume
29
Issue
3
Start Page
267
End Page
274
